Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-371,718
Closed -$3.04M 1142
2024
Q1
$3.04M Buy
371,718
+163,956
+79% +$1.15M 0.01% 676
2023
Q4
$1.44M Buy
+207,762
New +$1.53M ﹤0.01% 788
2023
Q3
Sell
-180,300
Closed -$1.21M 1170
2023
Q2
$1.21M Buy
180,300
+12,600
+8% +$87.8K ﹤0.01% 807
2023
Q1
$1.18M Buy
+167,700
New +$1.16M ﹤0.01% 846
2022
Q1
Sell
-251,300
Closed -$1.34M 1254
2021
Q4
$1.34M Hold
251,300
﹤0.01% 912
2021
Q3
$1.16M Hold
251,300
﹤0.01% 950
2021
Q2
$1.14M Sell
251,300
-123,700
-33% -$519K ﹤0.01% 981
2021
Q1
$1.56M Buy
+375,000
New +$1.32M ﹤0.01% 888
2018
Q3
Sell
-12,309
Closed -$90K 1399
2018
Q2
$90K Hold
12,309
﹤0.01% 1330
2018
Q1
$84K Sell
12,309
-298
-2% -$2.26K ﹤0.01% 1352
2017
Q4
$96K Buy
12,607
+785
+7% +$5.91K ﹤0.01% 1329
2017
Q3
$95K Sell
11,822
-1,263
-10% -$9.23K ﹤0.01% 1296
2017
Q2
$100K Sell
13,085
-46,600
-78% -$435K ﹤0.01% 1226
2017
Q1
$646K Sell
59,685
-12,960
-18% -$150K ﹤0.01% 1029
2016
Q4
$987K Sell
72,645
-46,765
-39% -$599K ﹤0.01% 911
2016
Q3
$1.58M Buy
119,410
+92,270
+340% +$1.38M 0.01% 815
2016
Q2
$427K Sell
27,140
-37,965
-58% -$608K ﹤0.01% 1038
2016
Q1
$905K Sell
65,105
-8,050
-11% -$93K ﹤0.01% 889
2015
Q4
$849K Sell
73,155
-41,552
-36% -$546K ﹤0.01% 947
2015
Q3
$1.31M Sell
114,707
-95,446
-45% -$1.34M 0.01% 861
2015
Q2
$4.26M Buy
210,153
+92,613
+79% +$2.17M 0.02% 627
2015
Q1
$2.54M Buy
117,540
+108,436
+1,191% +$2.47M 0.01% 748
2014
Q4
$201K Sell
9,104
-241
-3% -$6.57K ﹤0.01% 1265
2014
Q3
$313K Sell
9,345
-104
-1% -$3.84K ﹤0.01% 1162
2014
Q2
$384K Sell
9,449
-534
-5% -$19.8K ﹤0.01% 1136
2014
Q1
$334K Buy
+9,983
New +$322K ﹤0.01% 1141

Other funds holding VRN

Axa's VRN Position: Q2 2024 in Review

Axa sold out of Veren (VRN) in Q2 2024, closing a stake of 371,718 shares — an estimated $3.04M sold.

Axa first reported a position in VRN in Q1 2014 and held it in 26 quarters. The position peaked at $4.26M in Q2 2015. 193 funds tracked by Wall St. Rank hold VRN as of Q2 2024.

  • Axa reported no remaining Veren position as of Q2 2024 after selling out during the quarter.
  • Axa sold 371,718 Veren shares in Q2 2024, an estimated $3.04M.
  • Axa first reported a position in Veren in Q1 2014 and held it in 26 quarters.
  • Axa's Veren position peaked at $4.26M in Q2 2015.
  • 193 funds tracked by Wall St. Rank held Veren as of Q2 2024.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.